Press Releases Events & Presentations Press Releases Year None20202019201820172016201520142013201220112010 May 19, 2020 Assembly Biosciences Announces Move to Virtual-Only Annual Meeting of Stockholders on June 11, 2020 View HTML PDF Version May 07, 2020 Assembly Biosciences Reports Updates on Corporate Progress and First Quarter 2020 Financial Results View HTML PDF Version May 04, 2020 Preclinical Data from Assembly Biosciences’ Microbiome Program in Ulcerative Colitis Featured in DDW 2020 Virtual Meeting Portal and Upcoming Journal Supplements View HTML PDF Version May 01, 2020 Assembly Biosciences Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) View HTML PDF Version Apr 30, 2020 Assembly Biosciences to Host Conference Call and Webcast to Review HBV Portfolio Progress View HTML PDF Version Apr 06, 2020 Research by Assembly Biosciences and Academic Collaborators Published in Hepatology Indicates cccDNA Turnover Time May Enable Hepatitis B Cures Following Finite Therapy View HTML PDF Version Mar 31, 2020 Assembly Biosciences Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) View HTML PDF Version Mar 30, 2020 Assembly Biosciences Appoints Jason Okazaki as Chief Legal and Business Officer View HTML PDF Version Mar 04, 2020 Assembly Biosciences Reports Fourth Quarter and Year End 2019 Financial Results View HTML PDF Version Feb 19, 2020 Assembly Biosciences to Present at the 9th Annual SVB Leerink Global Healthcare Conference View HTML PDF Version Shareholder Tools Print Email Alerts Printed Materials RSS News Feeds Search Investors
Press Releases Year None20202019201820172016201520142013201220112010 May 19, 2020 Assembly Biosciences Announces Move to Virtual-Only Annual Meeting of Stockholders on June 11, 2020 View HTML PDF Version May 07, 2020 Assembly Biosciences Reports Updates on Corporate Progress and First Quarter 2020 Financial Results View HTML PDF Version May 04, 2020 Preclinical Data from Assembly Biosciences’ Microbiome Program in Ulcerative Colitis Featured in DDW 2020 Virtual Meeting Portal and Upcoming Journal Supplements View HTML PDF Version May 01, 2020 Assembly Biosciences Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) View HTML PDF Version Apr 30, 2020 Assembly Biosciences to Host Conference Call and Webcast to Review HBV Portfolio Progress View HTML PDF Version Apr 06, 2020 Research by Assembly Biosciences and Academic Collaborators Published in Hepatology Indicates cccDNA Turnover Time May Enable Hepatitis B Cures Following Finite Therapy View HTML PDF Version Mar 31, 2020 Assembly Biosciences Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) View HTML PDF Version Mar 30, 2020 Assembly Biosciences Appoints Jason Okazaki as Chief Legal and Business Officer View HTML PDF Version Mar 04, 2020 Assembly Biosciences Reports Fourth Quarter and Year End 2019 Financial Results View HTML PDF Version Feb 19, 2020 Assembly Biosciences to Present at the 9th Annual SVB Leerink Global Healthcare Conference View HTML PDF Version
